Smoking cessation in patients with respiratory disease: existing treatments and future directions
- 3 May 2013
- journal article
- review article
- Published by Elsevier BV in The Lancet Respiratory Medicine
- Vol. 1 (3), 241-250
- https://doi.org/10.1016/s2213-2600(13)70063-8
Abstract
No abstract availableThis publication has 71 references indexed in Scilit:
- The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UKThe Lancet, 2013
- Combined pharmacotherapy and behavioural interventions for smoking cessationPublished by Wiley ,2011
- Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trialThe Lancet, 2011
- Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysisCMAJ : Canadian Medical Association Journal, 2011
- iPhone Apps for Smoking Cessation: A Content AnalysisAmerican Journal of Preventive Medicine, 2011
- Psychiatric Adverse Events in Randomized, Double-Blind, Placebo-Controlled Clinical Trials of VareniclineDrug Safety, 2010
- Comparative Effectiveness of 5 Smoking Cessation Pharmacotherapies in Primary Care ClinicsJAMA Internal Medicine, 2009
- A Randomized Placebo-Controlled Clinical Trial of 5 Smoking Cessation PharmacotherapiesArchives of General Psychiatry, 2009
- Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trialThorax, 2008
- Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trialBMJ, 2008